Last reviewed · How we verify
NCT05631743
VR-CBT With Inuit in Quebec
NA trial testing VR-CBT in Emotion Regulation in 40 participants. Currently enrolling.
31 October 2025
Quick facts
| Lead sponsor | Douglas Mental Health University Institute |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 15 July 2023 |
| Primary completion | 31 October 2025 |
| Estimated completion | 31 December 2025 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- VR-CBT
- Self-management
Conditions studied
- Emotion Regulation — all drugs for Emotion Regulation →
Sponsor
Douglas Mental Health University Institute
Who can join
Adults 14 to 60, any sex, with Emotion Regulation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study design is a two-arm randomized controlled pilot trial. The investigators will recruit Inuit in Montreal and randomly assign them to two treatment groups (n=20 each). The active psychotherapy group will receive a ten-week manualized virtual reality (VR) assisted cognitive-behavioral psychotherapy (VR-CBT) at the clinic and guided by a psychotherapist. The VR-CBT will aim at improving emotion regulation. The comparison group will use a VR self-management program, Calm Place, for guided relaxation during ten weeks at home. To evaluate outcome in both groups, the researchers will measure self-reports of emotion regulation, affect, distress and well-being, as well as a psychophysiological reactivity paradigm pre-post treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05631743
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Emotion Regulation
Currently open trials in the same condition.
- NCT07401212 — GUTLINK4KIDS Intervention · NA · recruiting
- NCT07100951 — Comparing Brief Psychoanalytic Couple Therapy and Emotionally Focused Therapy in Reducing Relationship Distress · NA · recruiting
- NCT06928480 — Effectiveness and Acceptability of the Unified Protocol for the Transdiagnostic Treatment of Emotional Disorders in Peop · NA · recruiting
- NCT06894277 — Internet-based Talking About Risk and Adolescent Choices: Health and Emotion Regulation Options · NA · recruiting
- NCT07273786 — The Effects of Group Social Work Intervention on Children's Emotional Intelligence, Emotion Regulation Skills and Empath · NA · active not recruiting
Other Douglas Mental Health University Institute trials
Trials by the same sponsor.
- NCT07002996 — Spatial Memory Training and Cognitive Function · NA · recruiting
- NCT06978465 — DIALOG: Understanding Disorganisation: A Language-focused Global Initiative in Psychosis · not yet recruiting
- NCT06978452 — Behavioural Development, Long-term Outcomes and Opportunities to Optimize Youth Mental Health Trajectories · recruiting
- NCT06978894 — Predicting Psychotic Relapse Using Speech-Based Early Detection · recruiting
- NCT06893393 — Virtual Travel Into Nature for Individuals With Lived Experience of Severe Mental Disorders · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05631743 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Douglas Mental Health University Institute
- Last refreshed: 12 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05631743.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing